Table: Rohto -2016/17 group results

Rohto Pharmaceutical

11/05/2017 07:00

May 11 (Reuters)-  
          Rohto Pharmaceutical Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            154.60          167.02         158.50        73.00     
                 (-7.4 pct)      (+10.0 pct)    (+2.5 pct)    (+2.4 pct)  
  Operating         15.45           15.68          15.60         6.20     
                 (-1.5 pct)      (+19.2 pct)    (+1.0 pct)    (-4.1 pct)  
  Recurring         15.96           15.34          16.00         6.50     
                 (+4.1 pct)      (+8.8 pct)     (+0.2 pct)    (-4.7 pct)  
  Net 
  Net               10.01            9.10          10.20         4.30     
                 (+10.0 pct)     (+5.4 pct)     (+1.9 pct)    (+2.6 pct)  
  EPS             87.95 yen       80.04 yen      89.54 yen    37.75 yen   
  EPS Diluted     87.57 yen       79.70 yen                               
  Ann Div         21.00 yen       20.00 yen      22.00 yen                
  -Q2 Div         10.00 yen       10.00 yen      11.00 yen                
  -Q4 Div         11.00 yen       10.00 yen      11.00 yen                
   
  NOTE - Rohto Pharmaceutical Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T 
  ((Tokyo Headline News Desk +813 6441 1812))